Nxu, Inc. Class A Common Stock

NXU

Börsenwert 5,39 Mio. $

Nxu continues to work towards imminent completion of merger with Verde Bioresins, Inc. Nxu continues to work towards imminent completion of merger with Verde Bioresins, Inc.

MESA, Ariz., March 27, 2025 (GLOBE NEWSWIRE) -- Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company focused on energy storage and charging solutions for the infrastructure we need to power our electrified future, today announced a planned reverse stock split of its shares of Class A common stock (the “common stock”) at a ratio of 1-for-20. The reverse stock split is expected to take effect as of 12:01 a.m. ET, on Monday, March 31, 2025, and shares of the Company's Class A common stock are expected to begin trading on a post-split basis on the Nasdaq Capital Market at the market open on March 31, 2025 under the existing trading symbol “NXU”.

MESA, Ariz., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company focused on energy storage and charging solutions for the infrastructure we need to power our electrified future, and Verde Bioresins, Inc. (“Verde”), a leader in sustainable product innovation and full-service bioplastics production, announced the approval of the merger by Nxu stockholders after completing a stockholder vote on February 11th, 2025.

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Nxu , Inc., (NASDAQ: NXU ), relating to a proposed merger with Verde Bioresins, Inc. Under the terms of the agreement, Nxu will acquire all of the issued and outstanding common shares of Verde in an all-stock transaction.

NEW YORK , Nov. 3, 2024 /PRNewswire/ --  Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Nxu, Inc., (NASDAQ: NXU ), relating to a proposed merger with Verde Bioresins, Inc. Under the terms of the agreement, Nxu will acquire all of the issued and outstanding common shares of Verde in an all-stock transaction.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Nxu, Inc. (NasdaqCM: NXU) (the “Company”) and Verde Bioresins, Inc. Pursuant to the terms of the agreement, shareholders of Nxu will own approximately 5% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to Nxu s.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Nxu, Inc. (NASDAQ: NXU) and Verde Bioresins, Inc. is fair to Nxu shareholders. Upon closing of the proposed transaction, Nxu stockholders will own approximately 5% of the combined company. Halper Sadeh encourages Nxu shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or zha.

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Nxu (NASDAQ: NXU) for possible breaches of fiduciary duty and other violations of law in its transaction with Verde. Click here to learn how to join our investigation or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. In the transaction, pre-merger Nxu stockholders will own approximately only 5% of the combined company. The transaction agreement unreasonably limits competing transactions for Nxu by imposing.

Combination intended to create significant shareholder value in pursuit of a sustainable future An Economically Feasible and Scalable Alternative Bioresin to Traditional Petroleum-based Plastics

Portfolio includes five issued patents and thirty-seven pending patent applications Portfolio includes five issued patents and thirty-seven pending patent applications